07.02.2013 Views

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

Final Program in it's entirety - MyGirlsBlood

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Posters, Tuesday and Wednesday<br />

Index of Poster Presenters cont’d<br />

31P22<br />

Quality of Life <strong>in</strong> Patients with Congenital Hemophilia and<br />

Inhibitors <strong>in</strong> Japan<br />

Taki M1 , Tatsunami S2 , Shirahata A2 , Mimaya J2 , Takedani H2 ,<br />

Mak<strong>in</strong>o K2 , Ohira K2 , Kojima K2 , Wada I2 , Yoshikawa K2 1Department of Pediatrics, St. Marianna University School<br />

of Medic<strong>in</strong>e Yokohama City Seibu Hospital, Kanagawa,<br />

Japan, and 2The Research Committee on QOL Study<br />

Regard<strong>in</strong>g Coagulation Disorders <strong>in</strong> Japan, Kanagawa, Japan<br />

31P23<br />

Quality of Life <strong>in</strong> Parents of Children with Hemophilia - Results<br />

of the ESCHQoL Study<br />

Tedgard U1 , Ljung R1 , Bull<strong>in</strong>ger M2 , von Mackensen S2 1Dept of Paediatrics, University Hospital, Malmo, Sweden,<br />

2Institute of Medical Psychology, University Medical Centre<br />

Hamburg-Eppendorf, Germany<br />

31P24<br />

Blood Coagulation Factor VIII Activity Simulation Software for<br />

Optimal Dosage and Adm<strong>in</strong>istration - for the Better Quality<br />

of Life<br />

Tomotsugu A, Yamauchi K<br />

Bayer Japan, Osaka, Japan<br />

31P25<br />

Quality of Life Related to Health <strong>in</strong> Children Affected with<br />

Hemophilia Under the Age of 15 by Community Valencia<br />

(Spa<strong>in</strong>)<br />

Vañó L1 , Laguna S1 , Varela JA1 , Vila E1 , Ramón JA1 , Daras V1 ,<br />

Espada L1 , Usach J1 , Perez S2 , Querol F2 , Aznar JA2 1 2 Asociación de Hemofilia de la Comunidad, and Unidad de<br />

Hemostasia y Trombosis del Hospital La Fe de Valencia, Spa<strong>in</strong><br />

31P26<br />

Choices for a Better Future: The Lessons Learnt from an<br />

Educational Project<br />

Villaca PR1 , Okazaki E1 , Amaral JA2 , Sandoval E1 , Santos V1 ,<br />

D’Amico E1 1Hospital Das Cl<strong>in</strong>icas - Universidade de Sao Paulo and<br />

Fundação Verzol<strong>in</strong>i Escola Politecnica - University of São<br />

Paulo, Brazil<br />

31P27<br />

Assessment of Health-Related Quality of Life <strong>in</strong> VWD Patients<br />

– Results of the VWD-QoL Pilot-Study<br />

Von Mackensen S<br />

University of Hamburg, Germany<br />

31P28<br />

Longitud<strong>in</strong>al Assessment of Health Related Quality of Life<br />

<strong>in</strong> Young Hemophilia Patients <strong>in</strong> Europe<br />

Von Mackensen S<br />

University of Hamburg, Germany<br />

86<br />

31P29<br />

Content Validity of the Paediatric Hemophilia Quality of Life<br />

Assessment Tool <strong>in</strong> Ch<strong>in</strong>a<br />

Wu R1 , Young NL2 , Zhang J1 , Luke KH3 , Hang M4 , Blanchette<br />

V4 , Sun J5 , Li X6 , Poon MC7 1 2 Beij<strong>in</strong>g Children’s Hospital, Beij<strong>in</strong>g, Ch<strong>in</strong>a, Laurentian<br />

University, Sudbury, ON, Canada, 3Children’s Hospital of<br />

Eastern Ontario, Ottawa, ON, Canada, 4Hospital for Sick<br />

Children, Toronto, ON, Canada, 5Nanfang Hospital, Nanfang,<br />

Ch<strong>in</strong>a, 6Chengdu Children’s Hospital, Chengdu, Ch<strong>in</strong>a,<br />

7University of Calgary Foothills Medical Centre, Calgary, AB,<br />

Canada<br />

RARE CLOTTING FACTOR DEFICIENCIES<br />

32P04<br />

S<strong>in</strong>gle Center Experience on Rare Inherited Clott<strong>in</strong>g Factor<br />

Deficiency<br />

Madkhali I, Owaidah T and Al-Zahrani H<br />

K<strong>in</strong>g Faisal Specialist Hospital and RC, Riyadh, Saudi Arabia<br />

32P05<br />

The Factor XIII Database: A Look <strong>in</strong>to the Mutational<br />

Spectrum of F13 A and B Genes<br />

Biswas A, Ivaskevicius V, Oldenburg J, Thomas A<br />

Institute of Experimental Hematology and Transfusion<br />

Medic<strong>in</strong>e, Bonn, Germany<br />

32P06<br />

Cl<strong>in</strong>ical Manifestations of Lebanese Population with<br />

Afibr<strong>in</strong>ogenemia<br />

Djambas Khayat C1, 2 , Bakhos- Asmar J1 , Germanos M2 ,<br />

Samaha H1 , Khayat G2 , Sakr S1 1Lebanese Association for Hemophilia, Beirut, Lebanon,<br />

2Hotel Dieu de France Hospital, Angers, France<br />

32P07<br />

Congenital Dysfibr<strong>in</strong>ogenemia: Association between Cl<strong>in</strong>ical<br />

Symptoms, Laboratory Parameters, and Genetic Mutations<br />

Flommersfeld S, Fischer R, Kemkes-Matthes B, Heid<strong>in</strong>ger K<br />

University Center of Transfusion Medic<strong>in</strong>e and Haemostasis,<br />

Giessen and Marburg, Germany<br />

32P08<br />

A Novel Nonsense Mutation Identified <strong>in</strong> a Congenital<br />

Afibr<strong>in</strong>ogenemia Patient (FGB exon 7: GLU 369X) from<br />

Tenerife, Canary Islands, Spa<strong>in</strong><br />

García Talavera J1 , Neerman-Arbez M2 , Marrero C1 , León<br />

A1 , de Agust<strong>in</strong> T3 1Hospital Universitario Ntra Sra de Candelaria, Tenerife,<br />

Canary Islands, Spa<strong>in</strong>,<br />

2Geneva University Medical Centre, Switzerland, Geneva,<br />

Switzerland, 3CSL Behr<strong>in</strong>g, Marburg, Germany

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!